Guideline‐concordant endometrial cancer treatment and survival in the Women's Health Initiative Life and Longevity After Cancer study

In the Women's Health Initiative (WHI) Life and Longevity After Cancer (LILAC) cohort, we examined predictors of guideline‐concordant treatment among endometrial cancer (EC) survivors and associations between receipt of guideline‐concordant treatment and survival. Receipt of guideline‐concordant EC treatment was defined according to year‐specific National Comprehensive Cancer Network (NCCN) guidelines. Multivariable logistic regression was used...